Tuberculosis Research and Treatment / 2023 / Article / Tab 1 / Research Article
Drug Resistance in Tuberculous Lymphadenitis: Molecular Characterization Table 1 Location and position of lymphadenopathy status of the study participant’s data (
) drowned from ALERT and St. Peter TB Specialized Hospital, Addis Ababa, Ethiopia 2020.
Variables Clinically suspected TBLN (%) Culture negative (%) Culture positive (%) Location of lymph node Unilateral right-sided 89 (40.8%) 69 (78.4%) 19 (21.6%) Unilateral left-sided 92 (42.2%) 68 (78.2%) 19 (21.8%) Bilateral 36 (16.5%) 23 (65.7%) 12 (34.29%) Generalized 1 (0.5%) 1 (100%) 0 Total 218 (100) 161 (76.3%) 50 (23.7%) Position of lymph node Anterior cervical 87 (39.9%) 65 (75.6%) 21 (24.4%) Posterior cervical 55 (25.2%) 40 (74.1%) 14 (25.9%) Supra clavicular 25 (11.5%) 17 (73.9%) 6 (26.1%) Axillary 22 (10.1%) 13 (65%) 7 (35%) Mandibular 9 (4.1%) 6 (75%) 2 (25%) Inguinal 16 (7.3%) 16 (100%) 0 Occipital 2 (1.0%) 2 (100%) 0 Femoral 1 (0.5%) 1 (100%) 0 Chest 1 (0.5%) 1 (100%) 0 Total 218 (100) 161 (76.3%) 50 (23.7%)